National Pharmaceutical Council

ROR: 027608a92

OpenAlex ID: I4405271300

Patient adherence to HIV medication regimens: a review of published and abstract reports

2002 · Linda Fogarty, Debra Roter, et al. · Patient Education and Counseling · 373

Health and Productivity as a Business Strategy

2007 · Ronald Loeppke, Michael Taitel, et al. · Journal of Occupational and Environmental Medicine · 217

Improving Transparency to Build Trust in Real-World Secondary Data Studies for Hypothesis Testing—Why, What, and How: Recommendations and a Road Map from the Real-World Evidence Transparency Initiative

2020 · Lucinda S. Orsini, Marc Berger, et al. · Value in Health · 137

PDF

Cost-sharing and adherence, clinical outcomes, health care utilization, and costs: A systematic literature review

2022 · Nicole Fusco, Brian Sils, et al. · Journal of Managed Care & Specialty Pharmacy · 107

PDF

Cost–effectiveness thresholds in the USA: are they coming? Are they already here?

2015 · Robert W Dubois · Journal of Comparative Effectiveness Research · 79

Real-World Evidence: Useful in the Real World of US Payer Decision Making? How? When? And What Studies?

2017 · Daniel C. Malone, Mary Brown, et al. · Value in Health · 71

PDF

Specialty Drug Coverage Varies Across Commercial Health Plans In The US

2018 · James D. Chambers, David D. Kim, et al. · Health Affairs · 67

The role and value of pharmaceutical marketing

1994 · R. Levy · Archives of Family Medicine · 65

Private sector risk-sharing agreements in the United States: trends, barriers, and prospects.

2015 · Louis P Garrison, Josh J Carlson, et al. · PubMed · 64

What Contributes Most to High Health Care Costs? Health Care Spending in High Resource Patients

2016 · Daryl Pritchard, Allison Petrilla, et al. · Journal of Managed Care & Specialty Pharmacy · 46

PDF

Prevalence of Avoidable and Bias‐Inflicting Methodological Pitfalls in Real‐World Studies of Medication Safety and Effectiveness

2021 · Katsiaryna Bykov, Elisabetta Patorno, et al. · Clinical Pharmacology & Therapeutics · 45

Standards and guidelines for observational studies: quality is in the eye of the beholder

2015 · Sally C. Morton, Monica R. Costlow, et al. · Journal of Clinical Epidemiology · 44

The Effect of Medical Technology Innovations on Patient Outcomes, 1990-2015: Results of a Physician Survey

2018 · David E. Wamble, Michael Ciarametaro, et al. · Journal of Managed Care & Specialty Pharmacy · 43

PDF

Urinary incontinence: Economic burden and new choices in pharmaceutical treatment

2006 · Richard Levy, Nancy Muller · Advances in Therapy · 43

No improvement in the reporting of clinical trial subgroup effects in high-impact general medical journals

2016 · Nicole B. Gabler, Naihua Duan, et al. · Trials · 40

PDF

Assessing Real-World Data From Electronic Health Records for Health Technology Assessment: The SUITABILITY Checklist: A Good Practices Report of an ISPOR Task Force

2024 · Rachael L. Fleurence, Seamus Kent, et al. · Value in Health · 35

PDF

Prescription Cost Sharing: Economic and Health Impacts, and Implications for Health Policy

1992 · Richard A. Levy · PharmacoEconomics · 34

Patient-Community Perspectives on Real-World Evidence: Enhancing Engagement, Understanding, and Trust

2019 · Elisabeth M. Oehrlein, Jennifer S. Graff, et al. · Patient · 31

PDF

Predictors of adherence to oral anticancer medications: An analysis of 2010-2018 US nationwide claims

2022 · Ami Vyas, Andrew Descoteaux, et al. · Journal of Managed Care & Specialty Pharmacy · 30

PDF

Availability of New Drugs and Americans??? Ability to Work

2005 · Frank R. Lichtenberg · Journal of Occupational and Environmental Medicine · 29

Improving transparency to build trust in real‐world secondary data studies for hypothesis testing—Why, what, and how: recommendations and a road map from the real‐world evidence transparency initiative

2020 · Lucinda S. Orsini, Brigitta Monz, et al. · Pharmacoepidemiology and Drug Safety · 28

PDF

Clinical Differences among Nonsteroidal Antiinflammatory Drugs: Implications for Therapeutic Substitution in Ambulatory Patients

1989 · Richard A. Levy, Dorothy L. Smith · DICP · 28

Health Care Spending Effectiveness: Estimates Suggest That Spending Improved US Health From 1996 To 2016

2022 · Marcia R. Weaver, Jonah Joffe, et al. · Health Affairs · 27

As Value Assessment Frameworks Evolve, Are They Finally Ready for Prime Time?

2019 · Robert W. Dubois, Kimberly Westrich · Value in Health · 27

Linkages Between Nursing and the Quality of Patient Care: A 2-Year Comparison

2013 · Mary D. Naylor, Ellen M. Volpe, et al. · Medical Care · 27

Works count: 251

Citation count: 5,803